GVR Report cover Real-time PCR & Digital PCR Market Size, Share & Trends Report

Real-time PCR & Digital PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital), By Product (Consumables, Instruments), By Application, And Segment Forecasts, 2019 - 2026

  • Published Date: May, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-1-68038-552-6
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 110

Report Overview

The global Real-time PCR (qPCR) and Digital PCR (dPCR) market size were valued at USD 2.25 billion in 2018. It is expected to expand at a CAGR of 8.5% during the forecast period. High prevalence of target diseases and rapid technological advancements such as the development of high performance and superior qPCR and dPCR systems are expected to be the key factors driving the growth.

U.S. qPCR & dPCR market size

According to the World Health Organization (WHO), cancer was among the leading causes of death responsible for 9.6 million deaths globally in 2018. The WHO estimates that 36.9 million individuals were infected with HIV in 2017. It also reported that infectious diseases were among the top causes of deaths worldwide in 2016. The rising cases of these diseases are anticipated to drive the market in near future.

Moreover continued efforts by PCR manufacturers to develop novel systems and kits to use in molecular testing are likely to further propel the growth of the qPCR and dPCR market. For instance, in January 2019, QIAGEN N.V. announced its plans for the development of next-generation dPCR systems, anticipated to be launched in 2020. The new systems are expected to offer highly automated workflows and quicker turnaround time as compared to current digital PCR platforms which are likely to provide a significant competitive advantage to the company.

Besides, a broad range of applications of qPCR and dPCR technologies is expected to further boost the adoption in an array of scientific disciplines. The technologies have wide-ranging applications in both basic and diagnostic research. They have been extensively used in areas, such as human genetic testing, forensic sciences, pathogen detection, and infectious disease testing. Expanding applications in food microbiology and veterinary medicine among other industries is expected to further fuel the market.

Technology Insights

Based on technology, the Real-time PCR (qPCR) and Digital PCR (dPCR) market are segmented into quantitative and digital. Quantitative PCR held the largest market share in terms of value in 2018. Continued demand in areas such as genetic variation analysis, gene expression analysis, and genotyping along with an increasing focus on the development of Point of Care (POC) platforms is anticipated to drive the segment.

Digital PCR is a next-generation testing method that helps precise quantification of nucleic acids. These systems offer superior sensitivity and accuracy compared to other PCR-based approaches, which is anticipated to help the segment register robust growth during the forecast period.

Product Insights

Based on the product, the market is segmented into consumables and reagents, instruments, and software and services. The consumables and reagents were the leading segments accounting for the largest market share in terms of value in 2018. The segment is projected to witness a strong growth rate as compared to other segments owing to the launch of new PCR test kits.

For instance, in October 2017, AOAC INTERNATIONAL, independent standards developing organization certified Bio-Rad Laboratories iQ-Check (Real-Time PCR Kit) as the Official Method of Analysis for Salmonella species detection in raw meat. The validation paved the way for use of the kit in a range of industrial applications in the meat industry.

Application Insights

Based on the application, the market is segmented into research, clinical, forensic, and others. The research application was the dominant segment in 2018. qPCR and dPCR systems are widely used for research applications such as stem cell research and genetic disease and oncology research.

Global qPCR and dPCR market share

The wide-spread use of these systems is attributed to features such as enhanced specificity and quicker turnaround time. The clinical application segment is estimated to register the fastest CAGR of 8.7% during the forecast period due to the increasing adoption of automated processes.

Regional Insights

North America led the regional segment in 2018, attributed to the launch of new systems and test kits by the PCR manufacturers. For instance, in September 2018, Thermo Fisher Scientific Inc. launched VetMAX MastiType, a qPCR-based test kit used for the rapid detection of mastitis-causing pathogens in the dairy herds. Moreover, the strong presence of major PCR manufacturers in this region coupled with increasing demand for rapid diagnostic tests is also expected to drive regional growth over the forecast period.

Asia Pacific is likely to witness the fastest CAGR of 11.1% during the forecast period. Rise in the patient pool owing to the high prevalence of chronic and infectious diseases coupled with increasing awareness among patients about early diagnosis of these diseases is anticipated to boost the demand for PCR products, in turn driving the growth of the market.

qPCR and dPCR Market Share Insights

Major market players have been consistently focusing on deploying strategic business measures to maintain their competitive position. The key measures adopted by the players include new product launches, entering into collaborations and partnerships with institutes and companies, and mergers and acquisitions.

For instance, in January 2019, QIAGEN N.V. announced the acquisition of FORMULATRIX’s digital PCR assets in a deal valued at USD 260 million. The acquisition augments well with the company’s strategy of launching new digital PCR platforms in 2020 by incorporating FORMULATRIX’s advanced dPCR technology.

Some of the prominent players that dominate the market for qPCR and dPCR are Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; Agilent Technologies, Inc.; bioMerieux S.A.; Fluidigm Corporation.; and F. Hoffman La Roche.

Real-time PCR (qPCR) & Digital PCR (dPCR) Market Report Scope

Report Attribute


The market size value in 2020

USD 3.0 billion

The revenue forecast in 2026

USD 4.9 billion

Growth Rate

CAGR of 8.5% from 2019 to 2026

The base year for estimation


Historical data

2014 - 2017

Forecast period

2019 - 2026

Quantitative units

Revenue in USD Million and CAGR from 2019 to 2026

Report coverage

Revenue forecast; company share; competitive landscape; growth factors and trends

Segments covered

Technology, product, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; France; Italy; Spain; Russia; China; Japan; India; South Korea; Australia; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; Agilent Technologies, Inc.; bioMerieux S.A.; Fluidigm Corporation.; F. Hoffman La Roche.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country; regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For this study, Grand View Research has segmented the global Real-time PCR (qPCR) and Digital PCR (dPCR) market report based on technology, product, application, and region:

  • Technology Outlook (Revenue, USD Million, 2014 - 2026)

    • Quantitative

    • Digital

  • Product Outlook (Revenue, USD Million, 2014 - 2026)

    • Consumables & Reagents

    • Instruments

    • Software & Services

  • Application Outlook (Revenue, USD Million, 2014 - 2026)

    • Clinical

      • Pathogen Testing

      • Blood Screening

      • Oncology Testing

      • Others

    • Research

    • Forensic and Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2026)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

      • Singapore

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.